Impact of a predefined mediastinal ROI on inter-observer variability of planar 123I-MIBG heart-to-mediastinum ratio

[1] Carrio I(2001)Cardiac neurotransmission imaging J Nucl Med 42 1062-1076

[2] Caldwell JH(2008)Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure J Nucl Med 49 234-241

[3] Link JM(1981)Myocardial imaging in man with I-123 meta-iodobenzylguanidine J Nucl Med 22 129-132

[4] Levy WC(2006)Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation Eur J Nucl Med Mol Imaging 33 866-870

[5] Poole JE(2010)Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients J Am Coll Cardiol 55 2769-2777

[6] Stratton JR(2009)Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: Results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion J Am Coll Cardiol 53 426-435

[7] Kline RC(2008)Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: A systematic review Eur Heart J 29 1147-1159

[8] Swanson DP(2010)Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology Eur J Nucl Med Mol Imaging 37 1802-1812

[9] Wieland DM(2004)Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: Implications for clinical studies J Nucl Cardiol 11 126-133

[10] Thrall JH(2012)Reproducibility of planar 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure Eur J Nucl Med Mol Imaging 39 1599-1608

[1] Carrio I(2001)Cardiac neurotransmission imaging J Nucl Med 42 1062-1076

[2] Caldwell JH(2008)Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure J Nucl Med 49 234-241

[3] Link JM(1981)Myocardial imaging in man with I-123 meta-iodobenzylguanidine J Nucl Med 22 129-132

[4] Levy WC(2006)Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation Eur J Nucl Med Mol Imaging 33 866-870

[5] Poole JE(2010)Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients J Am Coll Cardiol 55 2769-2777

[6] Stratton JR(2009)Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: Results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion J Am Coll Cardiol 53 426-435

[7] Kline RC(2008)Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: A systematic review Eur Heart J 29 1147-1159

[8] Swanson DP(2010)Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology Eur J Nucl Med Mol Imaging 37 1802-1812

[9] Wieland DM(2004)Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: Implications for clinical studies J Nucl Cardiol 11 126-133

[10] Thrall JH(2012)Reproducibility of planar 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure Eur J Nucl Med Mol Imaging 39 1599-1608